Posted on: March 25, 2026
Understanding early Alzheimer’s treatment options can make a significant difference in outcomes — and a landmark new study suggests those options may be more powerful than previously thought. For decades, families watching a loved one’s memory fade have been told the same difficult truth: there is no cure for Alzheimer’s disease. Slow it, perhaps — but not stop it, and certainly not reverse it. However, a clinical trial now published in the peer-reviewed Journal of Alzheimer’s Disease is challenging that assumption — and the results are giving families genuine reason for hope.
What the Study Found About Early Alzheimer’s Treatment
The trial was led by Dr. Kat Toups, along with Drs. Ann Hathaway, Deborah Gordon, and pioneering neurologist Dr. Dale Bredesen. It enrolled 25 participants between ages 50 and 76 — all diagnosed with either mild cognitive impairment (MCI, sometimes called pre-Alzheimer’s) or early-stage dementia. Rather than prescribing a single drug, the research team took a deeply individualized approach. Each participant was assessed for their specific drivers of cognitive decline, including inflammation, insulin resistance, hormonal deficiencies, toxic exposures, nutritional gaps, pathogens, and genetic risk factors.
Each person then followed a personalized nine-month protocol targeting their unique combination of contributors. In other words, the treatment was built around the individual — not a one-size-fits-all formula. The results were striking.
By the end of the study:
- 84% of participants showed measurable cognitive improvement.
- Cognitive performance rose from the 38th to the 63rd percentile — a 65.7% improvement on standardized testing.
- Brain MRI scans showed total gray matter loss improved from an expected 2.2% per year to a slightly positive +0.3% — an improvement of 114%.
- Hippocampal atrophy rates improved by 63%.
Dr. Toups, who has served as principal investigator on more than 20 long-term dementia trials, noted it was the first trial she had seen show actual improvement across multiple domains of brain function, as well as measurable improvement on MRI scans.
What This Means for Your Loved One
If someone you love has recently been diagnosed with MCI or early-stage Alzheimer’s, this research carries a clear and urgent message: early action matters. The participants in this study were in the early stages of decline — which is precisely why intervention was possible. Waiting for symptoms to become severe, on the other hand, dramatically narrows the window for meaningful improvement.
Additionally, this is not just a diagnosis — it’s the beginning of a complex medical journey. That journey benefits enormously from having knowledgeable, organized support navigating it alongside you. Coordinating multiple specialists, understanding new research, managing medications, and accessing local resources is a full-time undertaking for families that are already stretched thin.
How Alivity Care Advocates Supports Families Exploring Early Alzheimer’s Treatment Options
At Alivity Care Advocates, our care management team brings more than 50 years of combined experience helping Michigan families navigate exactly these kinds of moments. When cognitive decline enters the picture, questions come quickly: Which specialists should be involved? How do we coordinate care between providers? What local resources are available — and how do we access them?
Our comprehensive care management services are designed to take that burden off families. We assess the full care situation, develop a coordinated care plan, and advocate for your loved one every step of the way — connecting families to pre-screened resources across Southeast Michigan.
Specifically, we help by:
- Assessing the full care situation and identifying immediate needs
- Creating and coordinating a personalized care plan
- Collaborating with physicians, specialists, and other providers
- Connecting families to trusted local resources and services
- Monitoring and adjusting care as the situation evolves
If a family member is showing early signs of memory loss, the best time to establish a care plan is now. Our team can help you understand the landscape of early Alzheimer’s treatment options — including emerging approaches like precision medicine — and make sure nothing falls through the cracks. Learn more about how we help families navigating cognitive decline and reach out to schedule a complimentary consultation.
📞 Ready to Talk?
If a loved one is showing early signs of memory loss, now is the time to act.
Call Alivity Care Advocates at (248) 375-9125
or visit alivitycare.com to schedule your complimentary in-home consultation.